A Study to Evaluate Subjects Treated With rhuMab 2C4 (Pertuzumab) in a Previous Genentech Phase II Cancer Study
Clinical trial NCT00096941 · COMPLETED
Trial details
- NCT number
- NCT00096941
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-05-01
- Primary completion
- 2007-10-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.